Browsing byAuthorBornefalk-Hermansson, A
Showing results 1 to 6 of 6
Issue Date | Title | Author(s) |
2015-01-01 | Low-dose opioids should be considered for symptom relief also in advanced chronic obstructive pulmonary disease (COPD) | Ekström, M; Bornefalk-Hermansson, A; Abernethy, A; Currow, D |
2021-03-25 | Minimal clinically important differences for Dyspnea-12 and MDP scores are similar at 2 weeks and 6 months: follow-up of a longitudinal clinical study. | Ekström, M; Bornefalk, H; Sköld, CM; Janson, C; Blomberg, A; Sandberg, J; Bornefalk-Hermansson, A; Currow, DC; Johnson, MJ; Sundh, J |
2016-11-25 | Oxygen for breathlessness in patients with chronic obstructive pulmonary disease who do not qualify for home oxygen therapy | Ekström, M; Ahmadi, Z; Bornefalk-Hermansson, A; Abernethy, A; Currow, D |
2019-02-26 | REgistry-based randomized controlled trial of treatment and Duration and mortality in long-term OXygen therapy (REDOX) study protocol | Sundh, J; Bornefalk-Hermansson, A; Ahmadi, Z; Blomberg, A; Janson, C; Currow, DC; McDonald, CF; McCaffrey, N; Ekström, M |
2014-01-30 | Safety of benzodiazepines and opioids in very severe respiratory disease: National prospective study | Ekström, MP; Bornefalk-Hermansson, A; Abernethy, AP; Currow, DC |
2018-09-01 | Spirometric volumes and breathlessness across levels of airflow limitation: The CopDGene study | Ekström, M; Bornefalk-Hermansson, A; Wysham, N; Currow, DC; MacIntyre, N |